medical appointment

University of Minnesota Launches COVID-19 Clinical Trials of Blood Pressure Drug Losartan

April 20, 2020

Researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other for diagnosed patients who do not require a hospital stay.

Other News

COVID-19 Medical Check list
It is startling to see the words “now in the third year of the pandemic” in print, but here we are.
Band aid with heart
The CDC has switched from talking about being “fully vaccinated” to staying “up to date on vaccinations.”
data, science concept
President Gabel announced some drop in the mask policy on UMN Twin Cities campus. But does that mean we're out of the clear?